The KFDA stopped market supplying of Cisapride preparations, a gastrointestinal drug, from Oct. 25, and Janssen Korea, the supplier of Cisapride, and other 10 companies expressed to accept the measure.
The KFDA instructed to the drug maker to add cautions "A prior ECG test shall be performed before administration of the drug for the first time" and "The drug shall be used only in case of no ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.